🇦🇺 Australia Country × Condition
diffuse large b cell lymphoma Clinical Trials in Australia
Active clinical trials for diffuse large b cell lymphoma with research sites in Australia. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 5 // Recruiting: 5 Phases: Phase 1, Phase 2, Phase 3 // Updated: Daily
Total Trials
5
Recruiting Now
5
Country
🇦🇺 Australia
Active Trials in Australia (5)
NCT05006716 Phase 1, Phase 2
Recruiting
A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies
Enrollment
614 pts
Country
🇦🇺 Australia
BeOne Medicines
View Trial → NCT01804686 Phase 3
Recruiting
A Long-term Extension Study of PCI-32765 (Ibrutinib)
Enrollment
700 pts
Country
🇦🇺 Australia
Janssen Research & Development, LLC
View Trial → NCT06830759
Recruiting
Real-World Study to Assess Subcutaneous Epcoritamab in Adult Participants With Diffuse Large B-Cell and Follicular Lymphoma
Enrollment
700 pts
Country
🇦🇺 Australia
AbbVie
View Trial → NCT02227251 Phase 2
Recruiting
Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Enrollment
244 pts
Country
🇦🇺 Australia
Karyopharm Therapeutics Inc
View Trial → NCT05139017 Phase 2, Phase 3
Recruiting
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)
Enrollment
290 pts
Country
🇦🇺 Australia
Merck Sharp & Dohme LLC
View Trial → Frequently Asked Questions
How many diffuse large b cell lymphoma clinical trials are active in Australia?
There are currently 5 active clinical trials for diffuse large b cell lymphoma with sites in Australia, of which 5 are actively recruiting patients.
How can I join a diffuse large b cell lymphoma clinical trial in Australia?
To join a diffuse large b cell lymphoma clinical trial in Australia, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Australia directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are diffuse large b cell lymphoma trials in Australia?
Active diffuse large b cell lymphoma trials in Australia span Phase 1, Phase 2, Phase 3, Phase 2, Phase 2, Phase 3. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.